RIVANNA announced on October 22, 2026, that the U.S. Food and Drug Administration granted 510(k) clearance for BoneEnhance, a machine learning software module for the company's Accuro XV diagnostic ultrasound system. The module segments bone and surrounding tissues and supports visualization of skeletal anatomy in three dimensions during image review. The Charlottesville, Virginia-based company, which develops AI-enabled clinical decision-support systems, described BoneEnhance as the first…
This article has been indexed from Unite.AI
Read the original article:
RIVANNA Wins FDA Clearance for BoneEnhance AI Module on Accuro XV